The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP
Open accessAbstract
Vasopressin and its analogue 1-deamino-8-D-arginine vasopressin (DDAVP) are known to raise plasma von Willebrand factor (vWF) levels. DDAVP is used as a hemostatic agent for the treatment of von Willebrand's disease. However, its cellular mechanisms of action have not been elucidated. DDAVP, a specific agonist for the vasopressin V2 receptor (V2R), exerts its antidiuretic effect via a rise in cAMP in kidney collecting ducts. We tested the hypothesis that DDAVP induces vWF secretion by binding to V2R and activating cAMP-mediated signaling in endothelial cells. vWF secretion from human umbilical vein endothelial cells (HUVECs) can be mediated by cAMP, but DDAVP is ineffective, presumably due to the absence of V2R. We report that DDAVP stimulates vWF secretion in a cAMP-dependent manner in HUVECs after transfection of the V2R. In addition, vasopressin and DDAVP induce vWF secretion in human lung microvascular endothelial cells (HMVEC-L). These cells (but not HUVECs) express endogenous V2R, as shown by RT-PCR. Vasopressin-induced vWF secretion is mimicked by DDAVP and inhibited by the selective V2R antagonist SR121463B. It is mediated by cAMP, since it is inhibited by the protein kinase A inhibitor Rp-8CPT-cAMPS. These results indicate that vasopressin induces cAMP-mediated vWF secretion by a direct effect on endothelial cells. They also demonstrate functional expression of V2R in endothelial cells, and provide a cellular mechanism for the hemostatic effects of DDAVP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Vasopressin is a neurohormone that is synthesized in the hypothalamus and transported to the posterior pituitary (Brownstein et al., 1980), where it is released into the bloodstream during dehydration to act via vasopressin V 2 receptors on the kidneys to produce water retention (Kaufmann et al., 2000).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Kaufmann et al., 2000
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
Sadler, J. E. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.395 · Cited by 1,369
IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK
Sullivan, J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92463-6 · Cited by 969
Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells
Wagner, D. D. (1982) · The Journal of Cell Biology · doi:10.1083/jcb.95.1.355 · Cited by 703
Mannucci, P. M., Pareti, F. I., Ruggeri, Z. M., & Capitanio, A. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91197-7 · Cited by 604
Molecular cloning of the receptor for human antidiuretic hormone
Birnbaumer, M., Seibold, A. M., Gilbert, S., Ishido, M., Barberis, C., Antaramián, A., Brabet, P., & Rosenthal, W. (1992) · Nature · doi:10.1038/357333a0 · Cited by 539
Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., & Brownstein, M. J. (1992) · Nature · doi:10.1038/357336a0 · Cited by 524 · cited 1×
“This vasopressin receptor subtype is expressed in the principal cells of renal collecting ducts and mediates the antidiuretic effect of the hormone (7, 8).”
BackgroundDesmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 Years
Mannucci, P. M. (1997) · Blood · doi:10.1182/blood.v90.7.2515 · Cited by 436
Desmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 Years
Mannucci, P. M. (1997) · Blood · doi:10.1182/blood.v90.7.2515.2515_2515_2521 · Cited by 398
Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive Drugs
Mannucci, P. M., Åberg, M., Nilsson, I. M., & Robertson, B. (1975) · British Journal of Haematology · doi:10.1111/j.1365-2141.1975.tb00521.x · Cited by 391
Cited by
Sorted by citations
Items 201–274 of 274
A medical elaboration on von Willebrand disease with its dental management
Aparna, M. (2016) · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · doi:10.1016/j.ajoms.2016.06.005 · Cited by 2
Copeptin as a Biomarker of Microcirculation Alterations in Systemic Sclerosis
Maciejewska, M., Stec, A., Zaremba, M., Maciejewski, C., Rudnicka, L., & Sikora, M. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s409490 · Cited by 2
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-816988-9.00001-1 · Cited by 2
Vasopressin Receptors in Blood Vessels and Proliferation of Endotheliocytes
Khegay, I. I. (2021) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162021040129 · Cited by 2
Gene Therapy for Von Willebrand Disease
Chuah, M., Petrus, I., & VandenDriessche, T. (2011) · Wiley eBooks · doi:10.1002/9781444329926.ch20 · Cited by 2
Biosynthesis and Organization of von Willebrand Factor
Haberichter, S. L. (2011) · doi:10.1002/9781444329926.ch2 · Cited by 2
Treatment of Von Willebrand Disease: Desmopressin
Mannucci, P. M. (2005) · doi:10.1002/9780470987124.ch48 · Cited by 2
Reaction of Rat Renal Medullary Laminin to Prolonged Dehydration
Khegay, I. I. (2023) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093023040221 · Cited by 1
Bär, I., Groten, S. A., Barraclough, A., Bürgisser, P. E., van Kwawegen, C. B., Lenting, P. J., van Moort, I., Eikenboom, J. C. J., Leebeek, F. W. G., Voorberg, J., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2025018760 · Cited by 1
Desmopressin parenteral bei VWD 1, VWD 2A und Thrombozytopathie
Pollmann, H., & Siegmund, B. (2011) · Hämostaseologie · doi:10.1055/s-0037-1619746 · Cited by 1
Neurohormonal Regulation of Tumor Growth
Хегай, И. И. (2018) · Russian Journal of Genetics · doi:10.1134/s1022795418010064 · Cited by 1
von Willebrand Disease in Dental Clinic: An Exclusive Case Report with Review of Literature
Aparna, M. (2015) · Journal of Contemporary Dentistry · doi:10.5005/jp-journals-10031-1118 · Cited by 1
Kloosterman, R., Zago‐Schmitt, M., Grabell, J., Thibeault, L., Chaigneau, M., Hinds, M., Hopman, W. M., Bowman, M. L., Harpell, L., Johri, A. M., et al. (2022) · Haemophilia · doi:10.1111/hae.14699 · Cited by 1
Zethof, S. C., Netelenbos, T., de Vries, A. P. J., & Rotmans, J. I. (2025) · BMJ Case Reports · doi:10.1136/bcr-2025-267099 · Cited by 1
Angiopoietin-2 is released during anaphylactic hypotension in anesthetized and unanesthetized rats
Zhang, T., Shibamoto, T., Tanida, M., Taniguchi, M., Kuda, Y., Yang, W., & Kurata, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242026 · Cited by 1
Treatment of Von Willebrand Disease: Desmopressin
Mannucci, P. M. (2010) · doi:10.1002/9781444318555.ch47 · Cited by 1
On the Use of Desmopressin in von Willebrand Disease
Lethagen, S., Federici, A. B., & Castaman, G. (2011) · doi:10.1002/9781444329926.ch16 · Cited by 1
Hormones, 2. Peptides and Proteins: Hypothalamic–Pituitary and Calcitropic Hormones
Sandow, J. (2013) · Ullmann's Encyclopedia of Industrial Chemistry · doi:10.1002/14356007.a19_061.pub2 · Cited by 1
Mullins, E. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.07910-7 · Cited by 1
Biosynthesis and organization of von Willebrand factor
Haberichter, S. L. (2024) · doi:10.1002/9781119419525.ch2 · Cited by 1
Cardiovascular Peptides: Vasopressin
Rizk, N. N., Rossi, N. F., & Dunbar, J. C. (2006) · Elsevier eBooks · doi:10.1016/b978-012369442-3/50171-9
Intensivmedizinische Behandlung nach Polytrauma
Stocker, R. A. (2007) · Elsevier eBooks · doi:10.1016/b978-343724280-9.10019-x
Diabetes Insipidus, Molecular Biology of
Oksche, A., Pohl, P., Krause, G., & Rosenthal, W. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200300072
Contemporary Intensive Care Treatment for Patients with Severe Multiple Trauma
Stocker, R. A., Lenzlinger, P. M., & Stover, J. F. (2013) · Springer eBooks · doi:10.1007/978-3-540-88124-7_7
Hypothalamische und hypophysäre Hormone
Steinfelder, H. J., & Oetjen, E. (2013) · Elsevier eBooks · doi:10.1016/b978-3-437-42523-3.00027-0
Pharmacotherapy of von Willebrand disease
Franchini, M., & Lippi, G. (2013) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2013.801315
Determinants of plasma levels of von Willebrand factor and coagulation factor VIII
Nossent, A. Y. (2008) · Leiden Repository (Leiden University)
Investigating the Genetic Basis of Type 3 of Von Willebrand Disease (VWD)
Bowman, M. L. (2013) · QSpace (Queen's University Library)
Effects and outcome of hemostatic treatment in bleeding disorders
Stoof, C. (2016) · EUR Research Repository (Erasmus University Rotterdam)
DESMOPRESSIN IN THE TREATMENT DISORDERS
Mannucci, P. M., & Bianchi, A. (2012)
Molekulargenetische Grundlage einer Variante des von Willebrand-Syndroms Typ 2
Schneppenheim, R. (2010)
The role of central vasopressin V2 receptors in cardiovascular homeostasis
Milutinović‐Smiljanić, S. (2013) · doi:10.2298/bg20130620milutinovicsmiljanic
Identification of endothelial Weibel-Palade bodies by single organelle flow cytometry
Joel, M. (2005) · NORA - Norwegian Open Research Archives
Haberichter, S. L., Balistreri, M., Christopherson, P. A., Morateck, P. A., Gavazova, S., Bellissimo, D. B., Manco‐Johnson, M. J., Gill, J. C., & Montgomery, R. R. (2006)
Aberrant and Alternative Splicing of von Willebrand Factor
Hawke, L. G. (2015) · QSpace (Queen's University Library)
Casey, L. J. (2015) · QSpace (Queen's University Library)
Mechanisms Controlling Stem Cell Differentiation
Tran, T. D. N. (2015) · doi:10.31390/gradschool_dissertations.2193
The Vasopressin V2 Receptor Antagonists: The Vaptans
Naafs, M. A. (2018) · Global Journal of Endocrinological Metabolism · doi:10.31031/gjem.2018.02.000529
Green, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812954-8.00009-6
Perucca, J. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
No, J.-G., Byun, S.-J., Yang, H., Ock, S. A., Woo, J.-S., Lee, H.-C., Hwang, I., Kim, J., Park, S. H., Lee, J. Y., et al. (2018) · Journal of Animal Reproduciton and Biotechnology · doi:10.12750/jet.2018.33.3.129
The Molecular Basis of Von Willebrand Disease
Baronciani, L., & Mannucci, P. M. (2005) · doi:10.1002/9780470987063.ch17
Noncanonical effects of vasopressin in angiogenesis
Khegay, I. I. (2019) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj19.527
The molecular basis of von W illebrand disease
Baronciani, L. (2019) · doi:10.1002/9781119252863.ch18
[Clinical observation of desmopressin in the treatment of 15 patients with DDAVP].
Hou, M., Yu, Z., N, Z., Zhang, W., Bai, X., Cao, L., Su, J., Sha, P., Wang, Z. Y., & Ruan, C. (2019) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2019.04.009
Rittig, S., & Christensen, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374430-2.00006-7
Mannucci, P. M., & Cattaneo, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00060-2
Авдонин, П. П., Trufanov, S. K., Tsitrina, A. A., Рыбакова, Е. Ю., Goncharov, N. V., & Avdonin, P. V. (2021) · Biochemistry (Moscow) · doi:10.31857/s0320972521020019
Synthesis and crystal structure of (dimethyl sulfoxide)succinatodioxouranium
Shchelokov, R. N., Mikhaĭlov, Y. N., Orlova, I. M., Sergeev, A. V., Ashurov, Z. R., Tashev, M. T., & Parpiev, N. A. (1986) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
Baldo, B. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-30472-4_7
Treatment of von Willebrand Disease: Desmopressin
Mannucci, P. M. (2014) · doi:10.1002/9781118398258.ch52
The Role of Cholinergic Receptors in the Reactions of the Hemostasis System on Vasopressin
Grigorjeva, M., & Golubeva, M. G. (2022) · Biology Bulletin Reviews · doi:10.1134/s2079086422060056
Nesen, А. О., Savicheva, K. O., Semenovykh, P. S., & Гальчінська, В. Ю. (2022) · Ukrainian Journal of Nephrology and Dialysis · doi:10.31450/ukrjnd.3(75).2022.07
León, J. S. T., Dulcey, L., Quintero, D. L., Badillo, L. Y. E., Anaya, S. J. N., & Calderón, P. F. D. (2023) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v7i1.5080
The use of desmopressin in von Willebrand disease
Castaman, G., & Federici, A. B. (2024) · doi:10.1002/9781119419525.ch21
Regulation of von Willebrand factor expression
Ghorbanpour, E., & Lillicrap, D. (2024) · Wiley eBooks · doi:10.1002/9781119419525.ch4
Reaction of Kidney Medullary Laminin to Prolonged Dehydration of Rats
Khegay, I. I. (2023) · Российский физиологический журнал им И М Сеченова · doi:10.31857/s0869813923070051
The Role of Vasopressin and the Vasopressin Type V1a Receptor Agonist Selepressin in Septic Shock
刘, 澳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551359
Investigation of determinants of clearance of von Willebrand Factor in individuals with type 1 VWD
Millar, C. M. (2008) · UCL Discovery (University College London)
PVD Associated with ARDS and Post-COVID Syndromes
Craddock, V. D., Pandya, S. M., Spikes, L. A., & Dhillon, N. K. (2025) · Respiratory medicine · doi:10.1007/978-3-032-03581-3_11
Copeptin (Not Only) in Water and Sodium Disorders
Drugda, J., Gabalec, F., & Horáček, J. (2025) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2025.24
Biology of von Willebrand disease
Flood, V. H., & Haberichter, S. L. (2026) · Blood Advances · doi:10.1182/bloodadvances.2025016484
Physiopathologie de l’export de surface des récepteurs et transporteurs
Silva, E. D. (2023) · theses.fr (ABES) · doi:10.70675/62c3e228z16d6z4fe1za587zd8d5e2ee9c54
Fouillen, A., Couvineau, P., Mouillac, B., & Bous, J. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112835
Solernó, L. M., Llavona, C., Saud, Z. Y., Onassis, M. C., Gottardo, M. F., Ledesma, M. M., Alonso, D. F., & Garona, J. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1864843
Evaluation of desmopressin stimulation test specificity in healthy volunteers
Elenius, H., Brown, B. M., McGlotten, R., Moore, C., & Nieman, L. K. (2026) · Endocrine Connections · doi:10.1530/ec-26-0270
Lipoedema in an adolescent male following valproate discontinuation: a case report
Kemer, S., KEMER, A. Ö., Özdemir, E. C., & Yaman, A. (2026) · Journal of Rehabilitation Medicine · doi:10.2340/jrm.v58.46824
Metadata
- Authors
- Kaufmann, J. E., Oksche, A., Wollheim, C. B., Günther, G., Rosenthal, W., & Vischer, U. M.
- Affiliations
- University of Geneva (CH)
- Leibniz-Forschungsinstitut für Molekulare Pharmakologie (DE)
- Corresponding author
- Kaufmann, Jocelyne E.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-07-01
- Volume
- 106
- Issue
- 1
- Pages
- 107-116
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC314363
- OpenAlex
- W2052753575
- Cited by
- 275
- References
- 47
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 6 · 2023: 14 · 2022: 11 · 2021: 12 · 2020: 12 · 2019: 9 · 2018: 15 · 2017: 7 · 2016: 13 · 2015: 12 · 2014: 13 · 2013: 15 · 2012: 8
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Fonds National de la Recherche Luxembourg
- Helmut Horten Stiftung
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- vasopressin, von Willebrand factor secretion, V2 receptor, cAMP signaling, protein kinase A, endothelial cells, desmopressin, von Willebrand disease, hemostasis, lung microvascular endothelial cells
- MeSH terms
- Cyclic AMP, Arginine Vasopressin, Cells, Cultured, Deamino Arginine Vasopressin, Endothelium, Vascular, Humans, Lung, RNA, Messenger, von Willebrand Factor, Receptors, Vasopressin, Reverse Transcriptase Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
